TregTherapeutics
TregTherapeutics is a preclinical company developing a novel tolerogenic therapies to treat autoimmune disorders. Treg's lead candidate is focused on plaque psoriasis.
Alert Banner
Alert:Watch the Boston Globe Today’s video on why North Carolina is an attractive place to grow a life sciences business, including lower business costs and highly skilled workforce.
Close Search Window
